Delta Plus Group SA

Delta Plus Group SA maintains a debt-to-equity ratio of 0.72 and a current ratio of 1.51, indicating moderate leverage and acceptable short-term liquidity [doc:HA-latest]. However, its cash and equivalents of EUR 263,000 are significantly lower than its long-term debt of EUR 196.07 million, resulting in a negative net cash position [doc:HA-latest]. The company's profitability is reflected in a return on equity (ROE) of 11.43% and a return on assets (ROA) of 5.67%, both exceeding the typical thresholds for industrial and consumer cyclicals firms. Its operating margin of 12.3% (calculated from operating income of EUR 49.17 million on revenue of EUR 400.08 million) aligns with industry norms for PPE manufacturers [doc:HA-latest]. Delta Plus Group SA operates globally through subsidiaries in Europe, Asia, South America, and the Middle East, with no disclosed revenue concentration in any single region or segment. The company's five product lines—Head, Hand, Body, Foot, and Fall Protection—are marketed under a single brand, suggesting a diversified but internally consolidated business model [doc:HA-latest]. The company's revenue growth trajectory is not explicitly provided, but its operating cash flow of EUR 43.59 million and free cash flow of EUR 22.55 million suggest operational efficiency. Analysts have assigned a mean price target of EUR 63.00, with a median of EUR 63.00, and a mean recommendation of 1.50 (leaning toward strong buy) [doc:]. Risk factors include a medium liquidity rating and a negative net cash position, which could constrain flexibility in capital allocation or debt servicing. The company has a low dilution risk, with no difference between basic and diluted shares outstanding, and no recent dilutive events reported [doc:HA-latest]. Recent events include no disclosed earnings call transcripts or regulatory filings in the provided data. Analysts have issued one strong-buy and one buy recommendation, with no hold or sell ratings, indicating a generally positive outlook [doc:].